Radical cystectomy in women: Impact of the robot-assisted versus open approach on surgical outcomes.


Journal

Urologic oncology
ISSN: 1873-2496
Titre abrégé: Urol Oncol
Pays: United States
ID NLM: 9805460

Informations de publication

Date de publication:
04 2020
Historique:
received: 14 07 2019
revised: 10 11 2019
accepted: 02 12 2019
pubmed: 19 1 2020
medline: 13 4 2021
entrez: 19 1 2020
Statut: ppublish

Résumé

To perform a comparison of complications following open versus robot-assisted radical cystectomy (RC) among women who undergo the procedure. Studies comparing robotic to open RC have been mixed without a clear delineation of which patients benefit the most from one modality vs. the other, leading to continued debate. This was a retrospective study of women who underwent either open or robotic RC at the MD Anderson Cancer Center from 1/2014 to 6/2018. Co-morbidities, pathologic data, and complications were assessed with descriptive statistics, along with uni- and multivariable logistic regression. 122 women underwent either open (n = 76) or robotic (n = 46) RC. Open RC was associated with greater intraoperative blood loss (median EBL 775 ml vs. 300 ml, P < 0.001). In both uni- and multivariable analyses, open RC was associated with a greater odds of intraoperative transfusion compared to robotic RC (odds ratio 6.49, 95% CI 2.85-14.78, P < 0.001). Women undergoing open RC were also at greater odds of receiving 4 or more units of packed red blood cells (odds ratio 5.46 (1.75-17.02), P = 0.003). Robotic RC conferred a higher median lymph node yield (27 vs. 20 nodes, P, <0.001) and operative times (median 513 min vs. 391.5 min, P < 0.001). There were no differences in margin positivity, length of stay, or readmission rates at 30 and 90 days. Robotic RC was associated with a significantly lower risk of transfusion and EBL, and a higher median lymph node yield and operative time. Unique anatomic considerations may in part be responsible for these findings.

Identifiants

pubmed: 31953001
pii: S1078-1439(19)30492-2
doi: 10.1016/j.urolonc.2019.12.005
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

247-254

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Vikram M Narayan (VM)

Department of Urology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, TX.

Mohamed A Seif (MA)

Department of Urology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, TX.

Amy H Lim (AH)

Department of Urology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, TX.

Roger Li (R)

Department of Urology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

Justin T Matulay (JT)

Department of Urology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, TX.

Janet B Kukreja (JB)

Urology Division, Department of Surgery, University of Colorado School of Medicine, Denver, CO.

Wei Qiao (W)

Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX.

Hyunsoo Hwang (H)

Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX.

Jay B Shah (JB)

Department of Urology, Stanford University, Stanford, CA.

Louis Pisters (L)

Department of Urology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, TX.

Ashish M Kamat (AM)

Department of Urology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, TX.

Colin Dinney (C)

Department of Urology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, TX.

Neema Navai (N)

Department of Urology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: NNavai@mdanderson.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH